OPKO Health, a biopharmaceutical and diagnostics company, has acquired Barcelona-based Farmadiet Group. The acquisition allows OPKO to establish presence in the European Union and allows near term product commercialization synergies ...
Tags: OPKO Health, Farmadiet, Barcelona-based Farmadiet Group
Almac in Northern Ireland and VTU Technology in Austria have teamed up to offer joint services for the expression of recombinant proteins with site-specific modification and labeling such as PEGylation for half-life extension of proteins. ...
Tags: Almac, VTU Technology, expression of recombinant proteins
Jazz Pharmaceuticals is closing the sale of its women's health business to Meda, a specialty pharmaceutical company, for $95m in cash. The products listed in the sale are Elestrin, Gastrocrom, Natelle One, AVC Cream , Gesticare DHA and ...
Tags: women's health business, Elestrin, Gastrocrom, Natelle One, AVC Cream
RayBiotech has signed a master services agreement with a West Coast-based biopharmaceutical company to provide custom services in the area of preclinical research diagnostic testing. RayBiotech will leverage its antibody array ...
Tags: company cooperation, clinical technology, clinical service
TNI BioTech and Hubei Qianjiang Pharmaceutical have entered into a partnership to develop new cancer therapeutics. The cancer drugs will be based on TNI BioTech's patents covering Methionine Enkephalin. TNI BioTech will carry out ...
Tags: Hubei Qianjiang Pharmaceutical, cancer drugs, methionine enkephalin
INC Research, a clinical research organization, has selected Trial Interactive as its global electronic Trial Master File (eTMF) solution. Trial Interactive offers access to global project documentation, get rid of much of the travel ...
Tags: company cooperation, clinical solution, web-based clinical platform
S1 Biopharma, an early-stage biopharmaceutical company, has announced its foray into male sexual health with S1P-205, the drug in development to treat Hypoactive Sexual Desire Disorder (HSDD) in males. With the development of S1P-205, the ...
Tags: S1 Biopharma, male sexual health, S1P-205, drug
ProMetic Life Sciences and NantPharma have together formed an affiliate company, NantPro BioSciences, to develop and commercialize a plasma-derived biopharmaceutical product for the US market. The new US based company has entered into ...
Tags: affiliate company, plasma-derived biopharmaceutical product
Bristol-Myers Squibb, a biopharmaceutical company, has terminated the development of BMS-986094, an investigational NS5B nucleotide for the treatment of hepatitis C. Based on an ongoing assessment of patients in a Phase II study that the ...
Tags: BMS-986094, Bristol-Myers, hepatitis C, NS5B nucleotide
JUPITER, Fla., - Dyadic International, Inc. (OTC Pink: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale of enzymes and other proteins for the bioenergy, bio-based chemicals, biopharmaceutical ...
Tags: U.S.Patent, Dyadic International
Clinical-stage biopharmaceutical company Omeros Corporation said that it has discovered the proteins that activate the alternative pathway of the complement system as part of the company's mannan-binding lectin associated serine protease-2 ...
Tags: complement system, protease-2(MASP-2)program, pro-inflammatory protein
Clinical stage biopharmaceutical company, Tocagen, has entered into a partnership agreement with MRI Interventions and Brainlab. Under the collaboration, Tocagen will use MRI Interventions' ClearPoint neuro intervention system at selected ...
TI Pharma, Merck KGaA, Astellas Pharma and the Swiss Tropical and Public Health Institute (Swiss TPH) have entered into an international public-private partnership (PPP) to develop new pediatric formulation of praziquantel for the treatment ...
Tags: Pediatric Formulation, Swiss TPH, treatment of schistosomiasis
Clinical-stage biopharmaceutical company OXiGENE's acute myelogenous leukemia (AML) drug candidate, OXi4503, has received FDA orphan drug status. The second-generation anticancer agent with a dual-mechanism vascular disrupting feature ...
Ten biopharmaceutical companies, Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Pfizer, Genentech and Sanofi have established a non-profit organization ...
Tags: biopharmaceutical companies, non-profit organization, new medicines